Current status of cryotherapy for prostate and kidney cancer - Abstract

In terms of treating diseases, minimally invasive treatment has become a key element in reducing perioperative complications.

Among the various minimally invasive treatments, cryotherapy is often used in urology to treat various types of cancers, especially prostate cancer and renal cancer. In prostate cancer, the increased incidence of low-risk, localized prostate cancer has made minimally invasive treatment modalities an attractive option. Focal cryotherapy for localized unilateral disease offers the added benefit of minimal morbidities. In renal cancer, owing to the increasing utilization of cross-sectional imaging, nearly 70% of newly detected renal masses are stage T1a, making them more susceptible to minimally invasive nephron-sparing therapies including laparoscopic and robotic partial nephrectomy and ablative therapies. This article reviews the various outcomes of cryotherapy compared with other treatments and the possible uses of cryotherapy in surgery.

Written by:
Cho S, Kang SH.   Are you the author?
Department of Urology, Korea University Anam Hospital, Seoul, Korea.

Reference: Korean J Urol. 2014 Dec;55(12):780-8.
doi: 10.4111/kju.2014.55.12.780


PubMed Abstract
PMID: 25512811

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe